Oral Abstract Session
CKD-MBD and Kidney Stones: Novel Insights
October 24, 2024 | 04:30 PM - 06:00 PM
Location: Room 6D, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- Bones‚ Stones‚ and Mineral Metabolism
Moderators
Presentations
- Heparin Variants Differ in Their Effect on Fibroblast Growth Factor 23 and Fibroblast Growth Factor Receptor 4 Binding
04:30 PM - 04:40 PM
- Association of the Ratio of Intact-to-C-terminal Fibroblast Growth Factor 23 with Heart Failure with Preserved Ejection Fraction
04:40 PM - 04:50 PM
- Involvement of COMMD5 in Vascular Calcification in CKD
04:50 PM - 05:00 PM
- Spatial Detection and Consequences of Nonkidney Calcitriol Production as Assessed by Targeted Mass Spectrometry Imaging
05:00 PM - 05:10 PM
- Bone Sialoprotein Regulates Phosphate Metabolism and Reduces Hyperparathyroidism in Mice with CKD
05:10 PM - 05:20 PM
- Exercise Mimetic Restores Muscle and Bone Outcomes in a Rat Model of CKD
05:20 PM - 05:30 PM
- Noninvasive Method to Diagnose Renal Osteodystrophy: A Study on 19 Circulating MicroRNAs
05:30 PM - 05:40 PM
- Reliability of Time-Lapse High-Resolution Peripheral Quantitative CT (HR-pQCT) in Determining Bone Remodeling in Patients with ESKD
05:40 PM - 05:50 PM
- Acute Effect of High Fat Intake on Urinary Acidification Parameters in Uric Acid Stone Formers and Non-stone Forming Controls
05:50 PM - 06:00 PM